Psychosocial predictors of substance use in adolescents and young adults: Longitudinal risk and protective factors.


Journal

Addictive behaviors
ISSN: 1873-6327
Titre abrégé: Addict Behav
Pays: England
ID NLM: 7603486

Informations de publication

Date de publication:
10 2021
Historique:
received: 30 01 2020
revised: 01 04 2021
accepted: 08 05 2021
pubmed: 5 6 2021
medline: 25 6 2021
entrez: 4 6 2021
Statut: ppublish

Résumé

Many psychosocial factors have been implicated in the onset and escalation of substance use in adolescence and young adulthood. Typically, each factor explains a small amount of the variance in substance use outcomes, and effects are typically applied across a broad range of ages or computed from cross-sectional data. The current study evaluated the association of factors including social influence (e.g., peer substance use), cognitive features (e.g., alcohol expectancies), and personality and emotional characteristics (e.g., impulsivity and typical responses to stress) in substance use throughout adolescence and emerging adulthood (ages 13-25; N = 798). Mixed-effects models tailored for the accelerated longitudinal design employed in this study were constructed with psychosocial and developmental factors predicting alcohol and cannabis use. As most participants in the sample exhibited little or no substance use at baseline by design, we excluded baseline assessments and examined data from follow-up years 1, 2, 3, and 4. Interactions between age cohort, change in age, and psychosocial predictors of substance use revealed differing associations over the developmental window for alcohol and cannabis use. For example, positive alcohol expectancies and sensation seeking were most strongly associated with greater drinking after age 18, whereas sensation seeking was associated with increased cannabis use as early as age 15. Higher emotion regulation skills led to less cannabis use in younger ages (i.e., shallower slopes below age 17), but this protective effect diminished after age 17. Results highlight developmentally important factors that differentially contribute to substance use in adolescence and young adulthood. We also demonstrate the importance of developmentally sensitive analyses that maximize the value of data from accelerated longitudinal designs.

Identifiants

pubmed: 34087768
pii: S0306-4603(21)00170-2
doi: 10.1016/j.addbeh.2021.106985
pmc: PMC8240028
mid: NIHMS1710626
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

106985

Subventions

Organisme : NIAAA NIH HHS
ID : R37 AA010723
Pays : United States
Organisme : NIAAA NIH HHS
ID : U24 AA021697
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA021696
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA021691
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA021681
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA021692
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA021690
Pays : United States
Organisme : NIAAA NIH HHS
ID : U24 AA021695
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA021697
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA021695
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM103436
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Références

Alcohol Clin Exp Res. 2002 May;26(5):737-46
pubmed: 12045484
Nat Neurosci. 2018 Mar;21(3):315-323
pubmed: 29403031
J Stud Alcohol. 1987 Sep;48(5):483-91
pubmed: 3669677
Trends Cogn Sci. 2015 Oct;19(10):558-566
pubmed: 26419496
J Child Psychol Psychiatry. 2006 Mar-Apr;47(3-4):296-312
pubmed: 16492261
J Consult Clin Psychol. 1997 Feb;65(1):130-40
pubmed: 9103742
Psychol Addict Behav. 2018 Aug;32(5):517-527
pubmed: 29963874
J Consult Clin Psychol. 2002 Feb;70(1):67-78
pubmed: 11860058
Addict Behav. 2002 Nov-Dec;27(6):867-86
pubmed: 12369473
Pediatrics. 2008 Apr;121 Suppl 4:S273-89
pubmed: 18381494
J Psychopharmacol. 2014 Nov;28(11):1080-7
pubmed: 25237125
Brain Cogn. 2010 Feb;72(1):66-72
pubmed: 19942334
Nat Rev Neurosci. 2012 Sep;13(9):636-50
pubmed: 22903221
J Consult Clin Psychol. 2000 Dec;68(6):976-92
pubmed: 11142550
J Am Acad Child Adolesc Psychiatry. 2002 Dec;41(12):1495-502
pubmed: 12447037
Front Psychiatry. 2014 May 22;5:56
pubmed: 24904439
J Neurosci. 2019 Mar 27;39(13):2562-2572
pubmed: 30718321
J Stud Alcohol Drugs. 2017 Jul;78(4):617-622
pubmed: 28728644
Addict Behav. 2011 Oct;36(10):972-9
pubmed: 21665373
J Subst Abuse Treat. 2015 Apr;51:1-18
pubmed: 25300577
Neuropsychology. 2016 May;30(4):449-73
pubmed: 26752122
Addiction. 2015 Jan;110(1):71-9
pubmed: 25117029
Assessment. 2013 Feb;20(1):86-97
pubmed: 22096214
Am J Psychiatry. 2018 Apr 1;175(4):370-380
pubmed: 29084454
J Stud Alcohol Drugs. 2007 Sep;68(5):727-37
pubmed: 17690807
Addict Behav. 2005 Jun;30(5):1071-6
pubmed: 15893107
Pediatrics. 2008 Apr;121 Suppl 4:S252-72
pubmed: 18381493
Soc Cogn Affect Neurosci. 2006 Dec;1(3):165-74
pubmed: 18985103
Neuroimage. 2010 May 15;51(1):345-55
pubmed: 20188198
Psychol Addict Behav. 2011 Sep;25(3):415-25
pubmed: 21534645
Brain Cogn. 2014 Aug;89:3-14
pubmed: 24512819
Dev Sci. 2011 Mar;14(2):F1-10
pubmed: 21499511
Alcohol Clin Exp Res. 1995 Aug;19(4):1018-23
pubmed: 7485811
Alcohol Clin Exp Res. 2017 Jun;41(6):1154-1165
pubmed: 28421617
Addict Behav. 2004 Nov;29(8):1503-15
pubmed: 15451120
Br J Clin Psychol. 2017 Sep;56(3):235-252
pubmed: 28493489
Br J Math Stat Psychol. 2012 Feb;65(1):163-80
pubmed: 21950803
Exp Clin Psychopharmacol. 2001 Nov;9(4):389-98
pubmed: 11764015
Lancet Psychiatry. 2014 Dec;1(7):569-76
pubmed: 26361316
Addict Behav. 2014 Sep;39(9):1372-6
pubmed: 24636739
Pediatrics. 2008 Apr;121 Suppl 4:S290-310
pubmed: 18381495
Dev Psychopathol. 2013 Nov;25(4 Pt 2):1567-84
pubmed: 24342856
Sleep. 2016 Jul 01;39(7):1429-39
pubmed: 27253763
Exp Clin Psychopharmacol. 2004 Feb;12(1):27-38
pubmed: 14769097
Am J Psychiatry. 2011 Sep;168(9):894-903
pubmed: 21724665
J Subst Abuse. 1997;9:103-10
pubmed: 9494942
Addict Behav. 2007 Nov;32(11):2469-94
pubmed: 17590277
JAMA Psychiatry. 2013 Mar;70(3):334-42
pubmed: 23344135
Arch Pediatr Adolesc Med. 2006 Jul;160(7):739-46
pubmed: 16818840
Exp Clin Psychopharmacol. 2003 Aug;11(3):210-7
pubmed: 12940500
J Stud Alcohol Drugs. 2015 Nov;76(6):895-908
pubmed: 26562597
Psychol Addict Behav. 2010 Jun;24(2):198-208
pubmed: 20565146

Auteurs

Ty Brumback (T)

Northern Kentucky University, United States. Electronic address: brumbackt1@nku.edu.

Wesley Thompson (W)

University of California, San Diego, United States.

Kevin Cummins (K)

University of California, San Diego, United States.

Sandra Brown (S)

University of California, San Diego, United States.

Susan Tapert (S)

University of California, San Diego, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH